The clinical-stage biotechnology company announced an 85% remission rate in evaluable frontline AML patients treated with mipletamig in combination with standard-of-care venetoclax and azacitidine.

Investing.com -- AST SpaceMobile Inc (NASDAQ: ASTS) stock surged 6.3% following the announcement of a strategic partnership ...

Riley analysts see Meta’s recent investment in Scale AI as a bullish signal for Reddit’s future, highlighting the rising value of unique data sources in the artificial intelligence arms race. “We view ...

Biomea Fusion Inc (NASDAQ: BMEA) stock tumbled 27.4% after the clinical-stage diabetes and obesity company announced plans for an underwritten public offering of ...

Scholar Rock Holding Corp (NASDAQ:SRRK) stock surged 16.4% after the company announced positive results from its Phase 2 EMBRAZE trial evaluating apitegromab in combination with tirzepatide for ...